Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM-030 gel in adults with Melasma
NCT06454747Phase 2Recruiting
- Sponsor
- DermBiont, Inc.
- Start
- Jun 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ruboxistaurin in melasma, sponsored by DermBiont, Inc.. Started Jun 2024; status: recruiting.
02
Drugs
ruboxistaurin
03
Conditions
melasma
Beyond the preview
Go deeper on NCT06454747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06454747.